Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ABOS —
ACUMEN PHARMACEUTICALS INC
CUSIP: 00509G209 · Held by 2 superinvestors · Combined value: $1,677,836
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $892,741 | 423,100 | REDUCE | -161,192 |
| 2 | Ken Griffin | 0.0% | $785,095 | 372,083 | REDUCE | -133,625 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -161,192 | -27.6% |
| Ken Griffin | REDUCE | -133,625 | -26.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +337,704 | +137.0% |
| Ken Griffin | ADD | +491,408 | +3436.4% |
Who Owns ABOS? Superinvestor Holdings
ACUMEN PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $2 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter2 reduced or exited.